| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2019 | EMBERA NEUROTHERAPEUTICS INC | 29 BABE RUTH DR | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 3 | NIH | 2/12/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 3 | NIH | 6/7/2022 | $0 |
| | 2022 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 001 | 3 | NIH | 8/16/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 3 | NIH | 7/28/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 3 | NIH | 11/7/2019 | $0 |
| | 2020 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 001 | 3 | NIH | 11/12/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $3,380,100 ) |
| | 2019 | 2019 | EMBERA NEUROTHERAPEUTICS, INC. | 29 BABE RUTH DRIVE | SUDBURY | MA | 01776-1943 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 001 | 3 | NIH | 8/13/2019 | $3,380,100 |
| | 2019 | 2018 | EMBERA NEUROTHERAPEUTICS, INC. | 365 BOSTON POST RD STE 210 | SUDBURY | MA | 01776-3043 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 2 | NIH | 12/3/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $3,762,556 ) |
| | 2018 | 2018 | EMBERA NEUROTHERAPEUTICS, INC. | 365 BOSTON POST RD STE 210 | SUDBURY | MA | 01776-3043 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 002 | 2 | NIH | 8/17/2018 | $1,881,278 |
| | 2018 | 2018 | EMBERA NEUROTHERAPEUTICS, INC. | 2031 KINGS HWY STE 230 | SHREVEPORT | LA | 71103-3600 | CADDO | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 001 | 2 | NIH | 2/2/2018 | $1,881,278 |
| | 2018 | 2016 | EMBERA NEUROTHERAPEUTICS, INC. | 2031 KINGS HWY STE 230 | SHREVEPORT | LA | 71103-3600 | CADDO | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 1 | NIH | 2/2/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | EMBERA NEUROTHERAPEUTICS, INC. | 2031 KINGS HWY STE 230 | SHREVEPORT | LA | 71103-3600 | CADDO | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 1 | NIH | 5/25/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $4,057,614 ) |
| | 2016 | 2016 | EMBERA NEUROTHERAPEUTICS INC | 365 BOSTON POST ROAD | SUDBURY | MA | 01776 | MIDDLESEX | USA | U01DA038879 | EMB-001: A novel combination therapy for the treatment of cocaine-use disorder | 000 | 1 | NIH | 7/20/2016 | $4,057,614 |
|
|
